Back
ESC Premium Access

Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity

Session: Cardio-oncology
Topic: Cardio-Oncology
Speaker: Doctor L. Michel (Essen, DE)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lars Michel

University of Duisburg-Essen - West-German Heart and Vascular Center, Essen (Germany)
1 presentation
1 follower

5 more presentations in this session

Echocardiography for the 10-year prediction of cardiomyopathy in long-term survivors of childhood cancer

Speaker: Mr J. Leerink (Amsterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways

Speaker: Doctor V. Quagliariello (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Tamponade during immune checkpoint inhibitors therapy in lung cancer: case-reports and systematic review of the literature

Speaker: Doctor H. Mustafic (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin 6 axis and mTORC1 /Fox01/3a mediated apoptosis

Speaker: Doctor V. Quagliariello (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular risk factors during cancer treatment: prevalence, incidence and prognostic relevance.

Speaker: Mr J. Caro Codon (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardio-oncology

Speakers: Doctor L. Michel, Mr J. Leerink, Doctor V. Quagliariello, Doctor H. Mustafic, Doctor V. Quagliariello...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources